Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer
Autor Milind Javle MD, Mitesh J. Borad MDen Limba Engleză Paperback – 22 aug 2023
- Covers gastrointestinal cancer targets—stage 1, 2, and 3 trials and preliminary results, as well as approved therapies.
- Includes sections on Sequencing Technologies, and Targeted and Immunotherapy Agents.
- Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction.
- Highlights FDA approvals throughout.
- Pocket-sized and color coded to help you find information quickly and easily.
- Read directly on your preferred device(s), such as computer, tablet, or smartphone.
- Easily convert to audiobook, powering your content with natural language text-to-speech.
Preț: 356.18 lei
Preț vechi: 374.92 lei
-5%
Puncte Express: 534
Preț estimativ în valută:
68.19€ • 73.95$ • 57.44£
68.19€ • 73.95$ • 57.44£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781975162948
ISBN-10: 1975162943
Pagini: 288
Dimensiuni: 108 x 181 mm
Greutate: 0 kg
Ediția:First
Editura: LWW
Colecția Lww
ISBN-10: 1975162943
Pagini: 288
Dimensiuni: 108 x 181 mm
Greutate: 0 kg
Ediția:First
Editura: LWW
Colecția Lww
Descriere
Designed for quick, everyday reference, Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer provides a practical overview of this rapidly advancing field. Comprehensive yet concise, this easy-access resource by Dr. Milind Javle of MD Anderson Cancer Center and Dr. Mitesh J. Board of Mayo Clinic helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of investigational targeted agents and combinations of agents.
- Covers gastrointestinal cancer targets—stage 1, 2, and 3 trials and preliminary results, as well as approved therapies.
- Includes sections on Sequencing Technologies, and Targeted and Immunotherapy Agents.
- Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction.
- Highlights FDA approvals throughout.
- Pocket-sized and color coded to help you find information quickly and easily.
, Enrich Your eBook Reading Experience
- Read directly on your preferred device(s), such as computer, tablet, or smartphone.
- Easily convert to audiobook, powering your content with natural language text-to-speech.
,